Aveanna Healthcare Holdings Inc. (AVAH) vs Dyne Therapeutics, Inc. (DYN)

A side-by-side comparison of Aveanna Healthcare Holdings Inc. and Dyne Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVAH vs DYN

growth of $100 · dividends reinvested · last 5y
AVAH +3.1% (+0.6%/yr)DYN -17.5% (-3.8%/yr)AVAH compounded faster over this window
050100150200250Start $10020222023202420252026$103$82
AVAH DYN

AVAH vs DYN: by the numbers

  • •DYN is the larger company ($2.88B vs $2.66B market cap).
  • •AVAH is profitable (10.56% net margin) while DYN runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAVAHDYN
P/E ratio9.67N/A
Forward P/E14.84N/A
P/S ratio1.02N/A
P/B ratio9.264.10
EV / EBITDA13.13N/A
FCF yield5.95%N/A

Profitability

MetricAVAHDYN
Gross margin31.95%0.00%
Operating margin11.12%0.00%
Net margin10.56%0.00%
ROE95.64%-73.97%
ROIC15.45%-58.28%

Growth (annualized)

MetricAVAHDYN
Revenue CAGR (5Y)9.65%N/A
FCF CAGR (5Y)58.99%N/A
Total return CAGR (5Y)9.75%-0.38%

Frequently asked

Is AVAH or DYN more profitable?
AVAH runs the higher net margin — AVAH at 10.56% versus DYN at 0.00%.
How have AVAH and DYN total returns compared?
Over the past 5 years, AVAH delivered 9.75% and DYN delivered -0.38% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.